Lapatinib in Stage IV Melanoma With ERBB4 Mutations

NCT01264081 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

NIH

Sponsor class

Stopped Protocol would not be able to reach stated accrual.

Conditions

Malignant Melanoma

Interventions

DRUG: Lapatinib

Sponsor

National Cancer Institute (NCI)